Dishman Carbogen Amcis Limited has informed the Exchange regarding a press release dated April 21, 2025, titled "COMPANY S WHOLLY-OWNED SUBSIDIARY VIZ. CARBOGEN AMCIS (SHANGHAI) CO. LTD., RECEIVED DRUG MANUFACTURING LICENSE FROM THE NATIONAL MEDICAL PRODUCT ADMINISTRATION FOR ITS SHANGHAI SITE, CHINA".